Exchange: NASDAQ Sector: Healthcare Industry: Medical Devices
Current Signal: BUY (auto-tracking)
0.53% $9.43
America/New_York / 28 mar 2024 @ 16:00
FUNDAMENTALS | |
---|---|
MarketCap: | 362.95 mill |
EPS: | 0.250 |
P/E: | 37.72 |
Earnings Date: | May 06, 2024 |
SharesOutstanding: | 38.49 mill |
Avg Daily Volume: | 0.173 mill |
RATING 2024-03-28 |
---|
A+ |
Strong Buy |
RATINGS | ||
---|---|---|
Rating CashFlow: | Buy | |
Return On Equity: | Buy | |
Return On Asset: | Strong Buy | |
DE: | Neutral | |
P/E: | Strong Buy | |
Price To Book: | Buy |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE 37.72 | sector: PE -3.05 |
PE RATIO: COMPANY / INDUSTRY |
---|
0.17x |
Company: PE 37.72 | industry: PE 222.16 |
DISCOUNTED CASH FLOW VALUE |
---|
$11.61 (23.12%) $2.18 |
Date: 2024-03-29 |
Expected Trading Range (DAY) |
---|
$ 9.00 - 9.86 ( +/- 4.57%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-22 | Hoyt Casey | Sell | 26 000 | Common Shares |
2024-01-29 | Trahan Jeremy | Buy | 32 321 | Restricted Stock Units |
2024-01-29 | Trahan Jeremy | Buy | 10 774 | Phantom Share Units |
2024-01-29 | Moore Michael | Buy | 80 527 | Restricted Stock Units |
2024-01-29 | Moore Michael | Buy | 26 842 | Phantom Share Units |
INSIDER POWER |
---|
20.18 |
Last 100 transactions |
Buy: 832 291 | Sell: 553 795 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $9.43 (0.53% ) |
Volume | 0.178 mill |
Avg. Vol. | 0.173 mill |
% of Avg. Vol | 102.81 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % | Feb 9 - 14:12 | buy | $8.83 | N/A | Active |
---|
Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment (DME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company also leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), percussion vests, oxygen concentrator units, and other small respiratory equipment; and sells and rents DME and patient medical services. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management related solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.